Trials / Conditions / Cancer of the Pancreas

Cancer of the Pancreas

28 registered clinical trials studyying Cancer of the Pancreas — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Stereotactic Body Radiotherapy Plus FAK and RAF/MEK Inhibition in Advanced Pancreatic Adenocarcinoma NCT07126158	Washington University School of Medicine	Phase 2
Recruiting	MK2 Inhibitor in Combination With mFOLFIRINOX for Untreated Metastatic Pancreatic Ductal Adenocarcinoma NCT06648434	Washington University School of Medicine	Phase 1
Completed	Clinical Validation of a Blood Biomarker Test to Detect Early-Stage Pancreatic Cancer (VERIFI) NCT06947395	Immunovia, Inc.	—
Recruiting	MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial NCT05975593	Washington University School of Medicine	N/A
Completed	Neoantigen Vaccines in Pancreatic Cancer in the Window Prior to Surgery NCT05111353	Washington University School of Medicine	Phase 1
Terminated	NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid NCT05252390	Nuvation Bio Inc.	Phase 1
Active Not Recruiting	Stereotactic Body Radiotherapy and Focal Adhesion Kinase Inhibitor in Advanced Pancreas Adenocarcinoma NCT04331041	Washington University School of Medicine	Phase 2
Terminated	Immunologic Effects of CDX-301 and CDX-1140 in Resectable Pancreatic Cancer Patients NCT04536077	Washington University School of Medicine	Phase 2
Completed	Targeting Pancreatic Cancer With Sodium Glucose Transporter 2 (SGLT2) Inhibition NCT04542291	Washington University School of Medicine	Phase 1
Terminated	Neoantigen Peptide Vaccine Strategy in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Ch NCT03956056	Washington University School of Medicine	Phase 1
Withdrawn	A Pilot Study of BXCL701 in Patients With Pancreatic Cancer NCT04123574	BioXcel Therapeutics Inc	EARLY_Phase 1
Completed	Liposomal Irinotecan Plus 5-FU / LV Combined With Paricalcitol in Patients With Advanced Pancreatic Cancer Pro NCT03883919	Washington University School of Medicine	Phase 1
Unknown	Self-expandable Metal Stents Versus Multiple Plastic Stents for Palliation of Biliary Obstruction NCT03821025	University of Cape Town	N/A
Completed	A Phase 2 Trial of High-dose Ascorbate for Pancreatic Cancer (PACMAN 2.1) NCT02905578	Joseph J. Cullen	Phase 2
Terminated	Neoantigen DNA Vaccine in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy NCT03122106	Washington University School of Medicine	Phase 1
Terminated	CAR T Cell Immunotherapy for Pancreatic Cancer NCT03323944	University of Pennsylvania	Phase 1
Terminated	Daily Online Adaptation Versus Localization for MRI-Guided SBRT for Unresectable Primary or Oligometastatic Ab NCT02950025	Washington University School of Medicine	Phase 2
Terminated	MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors NCT02669914	Washington University School of Medicine	Phase 2
Completed	Epidural Analgesia Use in Pancreatic Resections NCT02681796	Washington University School of Medicine	Phase 1
Terminated	BVD-523 Plus Nab-paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Cancer NCT02608229	Washington University School of Medicine	Phase 1
Terminated	Tosedostat With Capecitabine in Patients With Metastatic Pancreatic Adenocarcinoma NCT02352831	Washington University School of Medicine	Phase 1 / Phase 2
Completed	Immune Checkpoint Inhibition (Tremelimumab and/or MEDI4736) in Combination With Radiation Therapy in Patients NCT02311361	National Cancer Institute (NCI)	Phase 1 / Phase 2
Completed	A Phase II Study of Pioglitazone for Patients With Cancer of the Pancreas NCT01838317	University of Texas Southwestern Medical Center	Phase 2
Terminated	Gemcitabine and CT-011 for Resected Pancreatic Cancer NCT01313416	Augusta University	Phase 2
Completed	Study at the Man of the Profile of Chimiokines in the Anorexia Bound to the Cancerous Cachexy NCT02830620	Centre Hospitalier Universitaire de Nice	N/A
Completed	Phase I Study of Stereotactic Body Radiation Therapy and FOLFIRINOX in the Neoadjuvant Therapy of Pancreatic C NCT01446458	Emory University	Phase 1
Completed	QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas NCT01231347	NantCell, Inc.	Phase 3
Terminated	Adenocarcinoma of the Pancreas Treated With Panitumumab and Gemcitabine Regimen to Investigate Overall Surviva NCT00613730	Amgen	Phase 2